About Seres Therapeutics, Inc. - Common Stock (MCRB)
Seres Therapeutics is a biotechnology company focused on developing innovative therapeutics that harness the power of the microbiome to treat various diseases, particularly gastrointestinal disorders. The company leverages its proprietary platform to identify and develop next-generation microbiome-based treatments, aiming to restore microbial balance in the human body and improve patient outcomes. Through its research and clinical programs, Seres strives to address unmet medical needs with transformative therapies that have the potential to change the standard of care in multiple therapeutic areas. Read More
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Halper Sadeh LLC, an investor rights law firm, is investigating whether Seres Therapeutics, Inc.’s (NASDAQ: MCRB) sale of its VOWST microbiome therapeutic business to Société des Produits Nestlé S.A is fair to Seres shareholders.
